Worth reading
66In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
66
Tsubo (approximate site area)Wording
Conditional
How definitive the wording is.Announced details
M₂ Omori Medical Mall PhilPark
Applicable field (uses covered by this announcement)
Healthcare, dispensing pharmacy, internal medicine, pediatrics, community medical infrastructure
Relationship between the counterparty and the company
Phil Company,Inc.3267
Relationship with the Company
The operating entity of the dispensing pharmacy scheduled to occupy the first floor of this project. Capital and personnel relationships: Not disclosed
CounterpartyNihon Chouzai Co., Ltd.
Location (as indicated in this announcement)
1-chome Omorikita, Ota-ku, Tokyo
Steel-frame structure, three stories above ground; site area of approximately 66 tsubo
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
| Item | Details |
|---|---|
| Names of Products / Services Covered | M₂ Omori Medical Mall PhilPark |
| Counterparty | Nihon Chouzai Co., Ltd. |
| Relationship with the Company | The operating entity of the dispensing pharmacy scheduled to occupy the first floor of this project. Capital and personnel relationships: Not disclosed |
| Applicable area | Healthcare, dispensing pharmacy, internal medicine, pediatrics, community medical infrastructure |
| Location | 1-chome Omorikita, Ota-ku, Tokyo |
| Location scale | Steel-frame structure, three stories above ground; site area of approximately 66 tsubo |
Items this document does not state (12)
Counterparty overviewContract ValueOffering priceContract DateLaunch dateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateQuantitative EffectsUsage historyImpact on Business PerformanceSource
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To give concrete form to the owner’s vision of making this location a hub supporting the health of local residents and to establish a new base supporting the community’s medical infrastructure.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.